Items tagged with Diagnostics
Practical guide to implement simultaneous testing for TB and COVID-19 (post)
Together with the United States Agency for International Development (USAID), the Stop TB Partnership has released a practical guide on the Implementation of Simultaneous Diagnostic Testing for COVID-19 and TB in High TB Burden Countries.
Outcomes of a multicomponent diagnostic strategy for TB Infection (post)
A multicomponent diagnostic strategy was found to increase the number of patients being tested, diagnosed, and treated for confirmed tuberculosis (TB) infection, according to results of a cluster-randomized study published in The New England Journal of Medicine.
Planning and budgeting tool for TB and drug-resistant TB testing (post)
19 January 2022 | Geneva: The Global Laboratory Initiative (GLI), with its secretariat at the World Health Organization (WHO) Global TB Programme, is pleased to release a Planning and Budgeting Tool for TB and Drug-Resistant TB Testing for calculation of quantities and costs of diagnostic products and laboratory supplies. The tool references product numbers and prices in the Stop TB Partnership Global Drug Facility (GDF) Diagnostics, Medical Devices, and other Health Products Catalog.
WHO policy statement: Use of alternative interferon-gamma release assays for the diagnosis of TB infection (post)
28 January 2022 | Geneva: Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beijing Wantai’s TB-IGRA and Qiagen QuantiFERON-TB Gold Plus products. This expands the range of tests available to detect TB infection. Full details are provided in the WHO policy statement.
Detecting TB outside the lungs (post)
According to the WHO, a total of 1.5 million people died from tuberculosis (TB) in 2020. It is second only to COVID-19 as a leading cause of death as a result of an infectious disease, with over 95% of cases and deaths occurring in developing countries.
Detecting diagnostic DNA: A microfluidic gated device for extraction of cell-free DNA (post)
Scientists from Japan and USA develop a microfluidic device for the purification of tuberculosis genomic DNA fragments from human-plasma sample.
Considerations for simultaneous testing of COVID-19 and TB in high-burden countries (post)
In a comment, published in The Lancet Global Health, FIND, the global alliance for diagnostics, described their experinece with two initiatives in India for simultaneous COVID-19 and TB testing, outlining key topics for countries considering the implementation of simultaneous testing.
AI algorithms identify TB on lateral chest X-rays (post)
March 2, 2022 -- Tuberculosis (TB) can be consistently detected on lateral chest x-rays by an ensemble of two different types of deep-learning networks, according to research published online February 24 in Frontiers in Genomics.
The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis (post)
A systematic analysis, published in The Lancet Microbe, presented the first catalogue, endorsed by the World Health Organization (WHO), of molecular targets for Mycobacterium tuberculosis complex drug susceptibility testing, intended to provide a global standard for resistance interpretation. The existence of this catalogue is expected to encourage the implementation of molecular diagnostics by national TB programs.
Lancet Series: Tuberculosis in the time of COVID-19 (post)
Executive Summary
Page 44 of 70 · Total posts: 0
←First 43 44 45 Last→